Depression and PrEP uptake, interruption, and adherence among young women in Uganda
- PMID: 36892945
- PMCID: PMC11293432
- DOI: 10.1080/09540121.2023.2177250
Depression and PrEP uptake, interruption, and adherence among young women in Uganda
Abstract
Depression is a common cause of morbidity globally and can impact adherence to medications, posing challenges to medication-based HIV prevention. The objectives of this work are to describe the frequency of depression symptoms in a cohort of 499 young women in Kampala, Uganda and to determine the association of depression symptoms with use of HIV pre-exposure prophylaxis (PrEP). Mild or greater depression, assessed by the patient health questionnaire (PHQ-9), was experienced by 34% of participants at enrollment. Participants with mild depression symptoms tended to uptake PrEP, request PrEP refills, and adhere to PrEP with similar frequency to women with no/minimal signs of depression. These findings highlight opportunities to leverage existing HIV prevention programs to identify women who may benefit from mental health services and may not otherwise be screened.Trial registration: ClinicalTrials.gov identifier: NCT03464266..
Keywords: Depression; HIV prevention; Mental health; PrEP.
Conflict of interest statement
Disclosures
Authors declare no conflicts of interests or competing interests.
Figures
References
-
- Cabral A, M. Baeten J, Ngure K, Velloza J, Odoyo J, E. Haberer J, Celum C, Muwonge T, Asiimwe S, Heffron R, & for the Partners Demonstration Project Team. (2018). Intimate Partner Violence and Self-Reported Pre-exposure Prophylaxis Interruptions Among HIV-Negative Partners in HIV Serodiscordant Couples in Kenya and Uganda. JAIDS Journal of Acquired Immune Deficiency Syndromes, 77(2), 154–159. 10.1097/QAI.0000000000001574 - DOI - PMC - PubMed
-
- Camlin CS, Koss CA, Getahun M, Owino L, Itiakorit H, Akatukwasa C, Maeri I, Bakanoma R, Onyango A, Atwine F, Ayieko J, Kabami J, Mwangwa F, Atukunda M, Owaraganise A, Kwarisiima D, Sang N, Bukusi EA, Kamya MR, … Havlir DV (2020). Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study. AIDS and Behavior, 24(7), Article 7. 10.1007/s10461-020-02780-x - DOI - PMC - PubMed
-
- Carroll HA, Hook K, Perez OFR, Denckla C, Vince CC, Ghebrehiwet S, Ando K, Touma M, Borba CPC, Fricchione GL, & Henderson DC (2020). Establishing reliability and validity for mental health screening instruments in resource-constrained settings: Systematic review of the PHQ-9 and key recommendations. Psychiatry Research, 291, 113236. 10.1016/j.psychres.2020.113236 - DOI - PMC - PubMed
-
- Castillo-Mancilla JR, Zheng J-H, Rower JE, Meditz A, Gardner EM, Predhomme J, Fernandez C, Langness J, Kiser JJ, Bushman LR, & Anderson PL (2013). Tenofovir, Emtricitabine, and Tenofovir Diphosphate in Dried Blood Spots for Determining Recent and Cumulative Drug Exposure. AIDS Research and Human Retroviruses, 29(2), 384–390. 10.1089/aid.2012.0089 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous